Hybrid closed-loop insulin delivery systems are transforming the management of type 1 diabetes. Young children with type 1 diabetes are arguably the most challenging age group to manage, due to ...

Michelle Monje is the Milan Gambhir Professor of Pediatric Neuro-Oncology at Stanford University, CA, USA, and a Howard ...

Physicians from Bochum have used a cancer treatment method to treat severe autoimmune diseases.

A groundbreaking clinical trial led by London Health Sciences Centre Research Institute (LHSCRI) and Western University's ...

“The Lancet report provides data to show firstly that too little is invested in adolescent health and well-being and secondly that investments do not align with the adolescent burden of disease ...

Journalists, by profession and nature, look for stories. We search for what’s new, important, long-awaited, surprising or hidden so we can share it and help people understand the world.

It was not until 2023 that Genentech began discussions with the US Food and Drug Administration (FDA) for approval of TNK for AIS. On February 28, 2025, based in particular on the design and results ...

This acquisition in neurology, one of Sanofi’s four strategic disease areas, enhances Sanofi’s early-stage pipeline and includes VG-3927, which will be evaluated in a phase 2 clinical study in ...

Because medically unexplained symptoms remain a major challenge, and considering the close relationship of symptoms described in shell shock with clinical neurology ... até 11 de novembro de 1918.